Teva Pharmaceutical Industries Limited (TEVA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 13.71B | 13.95B | 12.74B | 12.62B | 11.53B | 12.55B | 12.31B | 11.63B | 12.3B | 12.48B | 11.43B | 12.09B |
| Cash & Short-Term Investments | 3.74B | 3.56B | 2.2B | 2.16B | 1.7B | 3.3B | 3.32B | 2.26B | 2.99B | 3.23B | 2.25B | 2.67B |
| Cash Only | 3.74B | 3.56B | 2.2B | 2.16B | 1.7B | 3.3B | 3.32B | 2.26B | 2.99B | 3.23B | 2.25B | 2.67B |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 3.39B | 3.71B | 3.81B | 3.56B | 3.38B | 3.06B | 3.46B | 3.77B | 3.46B | 3.41B | 3.38B | 3.54B |
| Days Sales Outstanding | 80.28 | 73.42 | 75.72 | 75.7 | 74.51 | 70.93 | 76.77 | 78.91 | 81.78 | 70.11 | 82.73 | 81.82 |
| Inventory | 3.18B | 3.18B | 3.32B | 3.5B | 3.25B | 3.01B | 3.96B | 3.93B | 3.95B | 4.02B | 4.05B | 4.11B |
| Days Inventory Outstanding | 142.21 | 145.47 | 144.17 | 147.95 | 139.74 | 151.94 | 166.17 | 167.46 | 177.07 | 181.93 | 187.77 | 179.79 |
| Other Current Assets | 2.33B | 3.5B | 2.29B | 2.31B | 2.18B | 2.18B | 447M | 585M | 565M | 575M | 572M | 543M |
| Total Non-Current Assets | 26.33B | 26.8B | 27.12B | 27.51B | 26.89B | 26.77B | 29.44B | 29.71B | 30.48B | 30.99B | 30.66B | 31.01B |
| Property, Plant & Equipment | 4.33B | 4.42B | 5.16B | 5.17B | 4.99B | 4.95B | 6.04B | 5.93B | 5.98B | 6.15B | 6.03B | 6.13B |
| Fixed Asset Turnover | 0.91x | 0.98x | 0.87x | 0.82x | 0.78x | 0.77x | 0.72x | 0.70x | 0.63x | 0.73x | 0.63x | 0.63x |
| Goodwill | 15.82B | 16B | 15.95B | 15.95B | 15.48B | 15.15B | 16.12B | 16.49B | 17.01B | 17.18B | 16.89B | 17.12B |
| Intangible Assets | 3.61B | 3.78B | 3.94B | 4.14B | 4.19B | 4.42B | 4.76B | 4.85B | 5.06B | 5.39B | 5.53B | 5.74B |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 376M | 405M | 2.08B | 470M | 464M | 462M | 458M | 434M | 471M | 470M | 477M | 443M |
| Total Assets | 40.04B | 40.75B | 39.86B | 40.13B | 38.41B | 39.33B | 41.76B | 41.34B | 42.77B | 43.48B | 42.09B | 43.09B |
| Asset Turnover | 0.10x | 0.12x | 0.11x | 0.11x | 0.10x | 0.10x | 0.10x | 0.10x | 0.09x | 0.10x | 0.09x | 0.09x |
| Asset Growth % | 4.23% | 3.62% | -4.55% | -2.92% | -10.19% | -9.55% | -0.78% | -4.08% | -1.57% | -1.21% | -4.89% | -6.18% |
| Total Current Liabilities | 13.53B | 13.46B | 11.49B | 11.86B | 11.16B | 12.8B | 13.8B | 13.04B | 13.79B | 12.25B | 11.39B | 11.84B |
| Accounts Payable | 2.6B | 2.53B | 2.35B | 2.5B | 2.29B | 2.2B | 2.37B | 2.37B | 2.44B | 2.6B | 2.28B | 2.51B |
| Days Payables Outstanding | 114.73 | 109.32 | 102.59 | 105.04 | 100.39 | 99.76 | 99.82 | 102.16 | 111.99 | 110.03 | 110.18 | 106.84 |
| Short-Term Debt | 2.61B | 1.82B | 24M | 464M | 421M | 1.78B | 2.58B | 2.09B | 3.06B | 1.67B | 1.48B | 1.98B |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.62B | 0 |
| Other Current Liabilities | 7.77B | 9.11B | 2.89B | 5.8B | 5.49B | 8.81B | 8.23B | 5.74B | 7.8B | 5.2B | 483M | 4.86B |
| Current Ratio | 1.01x | 1.04x | 1.11x | 1.06x | 1.03x | 0.98x | 0.89x | 0.89x | 0.89x | 1.02x | 1.00x | 1.02x |
| Quick Ratio | 0.78x | 0.80x | 0.82x | 0.77x | 0.74x | 0.75x | 0.61x | 0.59x | 0.61x | 0.69x | 0.65x | 0.67x |
| Cash Conversion Cycle | 107.76 | 109.57 | 117.3 | 118.61 | 113.86 | 123.1 | 143.12 | 144.21 | 146.85 | 142.01 | 160.32 | 154.77 |
| Total Non-Current Liabilities | 18.28B | 19.38B | 21.11B | 21.44B | 20.99B | 20.81B | 21.58B | 21.74B | 21.44B | 23.11B | 23.18B | 23.54B |
| Long-Term Debt | 14.02B | 15.27B | 16.78B | 16.76B | 16.23B | 16B | 16.4B | 16.55B | 16.58B | 18.16B | 18.5B | 18.7B |
| Capital Lease Obligations | 280M | 288M | 283M | 296M | 288M | 296M | 295M | 281M | 294M | 320M | 324M | 338M |
| Deferred Tax Liabilities | 273M | 296M | 399M | 440M | 461M | 483M | 538M | 553M | 569M | 606M | 544M | 534M |
| Other Non-Current Liabilities | 3.71B | 3.52B | 3.66B | 3.94B | 4.01B | 4.03B | 4.34B | 4.36B | 3.99B | 4.02B | 3.82B | 3.97B |
| Total Liabilities | 31.81B | 32.84B | 32.6B | 33.3B | 32.15B | 33.61B | 35.37B | 34.77B | 35.23B | 35.35B | 34.58B | 35.39B |
| Total Debt | 16.91B | 17.38B | 17.09B | 17.52B | 16.94B | 18.08B | 19.27B | 18.92B | 19.94B | 20.15B | 20.3B | 21.02B |
| Net Debt | 13.17B | 13.83B | 14.89B | 15.36B | 15.24B | 14.78B | 15.96B | 16.66B | 16.95B | 16.93B | 18.05B | 18.35B |
| Debt / Equity | 2.05x | 2.20x | 2.36x | 2.56x | 2.70x | 3.16x | 3.02x | 2.88x | 2.64x | 2.48x | 2.70x | 2.73x |
| Debt / EBITDA | 18.98x | 31.04x | 15.11x | 24.82x | 22.20x | 75.33x | 92.67x | 74.50x | 369.22x | 19.72x | 32.37x | - |
| Net Debt / EBITDA | 14.78x | 24.69x | 13.16x | 21.76x | 19.98x | 61.58x | 76.71x | 65.61x | 313.83x | 16.56x | 28.79x | - |
| Interest Coverage | 3.17x | 1.27x | 4.09x | 2.00x | 2.31x | 1.17x | -0.19x | -0.05x | -0.87x | 4.81x | 1.23x | 2.50x |
| Total Equity | 8.23B | 7.91B | 7.25B | 6.83B | 6.27B | 5.72B | 6.38B | 6.56B | 7.54B | 8.13B | 7.51B | 7.71B |
| Equity Growth % | 31.31% | 38.35% | 13.63% | 4.13% | -16.89% | -29.61% | -15% | -14.85% | -12.4% | -5.49% | -21.09% | -21.57% |
| Book Value per Share | 6.98 | 6.75 | 6.23 | 5.89 | 5.41 | 5.05 | 5.63 | 5.79 | 6.72 | 7.15 | 6.62 | 6.88 |
| Total Shareholders' Equity | 8.23B | 7.91B | 7.25B | 6.83B | 6.26B | 5.37B | 6.07B | 6.36B | 7.28B | 7.51B | 6.93B | 7.05B |
| Common Stock | -4.07B | 58M | 58M | 58M | 58M | 58M | 58M | 58M | 58M | 57M | 57M | 57M |
| Retained Earnings | -13.39B | -13.76B | -14.24B | -14.68B | -14.96B | -15.17B | -14.96B | -14.52B | -13.67B | -13.53B | -13.87B | -13.95B |
| Treasury Stock | 0 | -4.13B | -4.13B | -4.13B | -4.13B | -4.13B | -4.13B | -4.13B | -4.13B | -4.13B | -4.13B | -4.13B |
| Accumulated OCI | -2.51B | -2.39B | -2.48B | -2.43B | -2.67B | -3.15B | -2.77B | -2.88B | -2.77B | -2.7B | -2.91B | -2.68B |
| Minority Interest | 4M | 4M | 4M | 7M | 7M | 347M | 319M | 204M | 265M | 620M | 582M | 656M |